S

Sofwave Medical Ltd
TASE:SOFW

Watchlist Manager
Sofwave Medical Ltd
TASE:SOFW
Watchlist
Price: 3 994 ILS -0.4% Market Closed
Market Cap: ₪1.4B

Sofwave Medical Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sofwave Medical Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
S
Sofwave Medical Ltd
TASE:SOFW
Research & Development
-$10.4m
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Research & Development
-$20.2m
CAGR 3-Years
-6%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Research & Development
-$9.1m
CAGR 3-Years
-6%
CAGR 5-Years
-13%
CAGR 10-Years
-7%
Inmode Ltd
NASDAQ:INMD
Research & Development
-$13.3m
CAGR 3-Years
-2%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Research & Development
-$15.9m
CAGR 3-Years
0%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
A
Alpha Tau Medical Ltd
NASDAQ:DRTS
Research & Development
-$32.1m
CAGR 3-Years
-15%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
No Stocks Found

Sofwave Medical Ltd
Glance View

Market Cap
1.4B ILS
Industry
Health Care

Sofwave Medical Ltd. engages in development, production, marketing, maintenance, and distribution of medical technology for firming and rejuvenating facial and neck skin. The firm operates itself and through its subsidiaries in the field of development, production, marketing, support and distribution of medical technology Sofwave that delivers Synchronous Ultrasound Parallel Beam SUPERB technology for skin tightening and rejuvenation treatments for the face and neck, which provides a non-invasive solution for skin rejuvenation and tightening, in a safe and clinically effective manner. In addition, the group provides services technical and clinical support for the product it provides. The firm has subsidiary in United States -Sofwave Medical Inc.

SOFW Intrinsic Value
910.04 ILS
Overvaluation 77%
Intrinsic Value
Price
S

See Also

What is Sofwave Medical Ltd's Research & Development?
Research & Development
-10.4m USD

Based on the financial report for Dec 31, 2024, Sofwave Medical Ltd's Research & Development amounts to -10.4m USD.

What is Sofwave Medical Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
-8%

Over the last year, the Research & Development growth was 6%. The average annual Research & Development growth rates for Sofwave Medical Ltd have been -8% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett